For the first time in almost a decade, another neurotoxin has entered the market and everyone’s now wondering: What is the new Botox called?
Aptly named Newtox, Jeuveau is the latest FDA-approved neuromodulator cleared to temporarily relax moderate to severe glabellar lines (wrinkles between the eyebrows).
To learn the ins and outs of Jeuveau Newtox, read on.
What Is the New Botox Called?
Like many, you may be curious to know more about the neurotoxin that recently joined the ranks of Botox, Dysport, and Xeomin. In fact, an increasing number of men and women have been asking: What is the new Botox called?
It is called Jeuveau and manufactured by Evolus. Providers are especially excited about Jeuveau’s arrival because it provides them with another tool to customize antiaging injectables to individual needs and goals.
How Does Jeuveau Work?
Jeuveau is an injectable treatment comprised of botulinum toxin type A. When injected into targeted muscles, it blocks communication between the nerve and muscle and temporarily inhibits contraction.
This paralytic effect subsequently relaxes wrinkles and lines for a period of three-to-four months.
Is Jeuveau the Same as Botox?
Jeuveau shares a number of similarities with Botox. To start, its molecular structure is identical to Botox, and it offers the same efficacy and safety profile. Accordingly, Jeuveau can be used to treat the same areas as Botox.
What’s more, both neuromodulators are derived from Clostridium botulinum bacteria and reduce wrinkles by weakening overactive muscles.
However, Jeuveau and Botox are manufactured by different companies and at separate facilities. They also have specific indications for use – Botox can be used for cosmetic and medical purposes, while Jeuveau is exclusively for cosmetic application.
Learn More About Jeuveau Newtox
If you’ve been wondering – What is the new Botox called? – call our office today to schedule a Jeuveau consultation with Dr. Narine.